跳至主要内容
临床试验/NCT00764257
NCT00764257已完成3 期

A Multicenter, Evaluator-Masked Study to Assess the Efficacy and Safety of Mentor's CX002 Dermal Filler Medical Device, When Applied as an Intradermal Implant for the Correction of Facial Wrinkles and Lip Augmentation (CX002 Dermal Filler Protocol)

Mentor Worldwide, LLC2 个研究点 分布在 1 个国家开始时间: 2004年10月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
试验地点
2
主要终点
Study the safety and efficacy of CX002 when applied to the NLFs or lips.

研究概览

简要总结

The purpose of this study was to assess PREVELLE Shape (CX002), with respect to safety and efficacy for one year following treatment, for correction of facial nasolabial folds and when applied as an intradermal implant for lip augmentation.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Study the safety and efficacy of CX002 when applied to the NLFs or lips.

时间窗: 1 year

The primary aim of the study is to assess CX002, with respect to safety and efficacy during the six months following treatment, in two subject cohorts: 1. When applied as an intradermal implant for the correction of facial nasolabial folds (Nasolabial Fold Cohort). Nasolabial folds were chosen as the fold/wrinkle for treatment as they are often the most severe facial wrinkles, representing a "worst-case" scenario 2. When applied as an intradermal implant for lip augmentation (Lip Augmentation Cohort)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

PREVELLE Shape (CX002) Dermal Filler Protocol | 临床试验